Toll-like receptors: Significance, ligands, signaling pathways, and functions in mammals

References

• Medzhitov R. Toll-like receptors and innate immunity. Nat Rev Immunol. 2001;1(2):135–145.
   PubMed Web of Science ®Google Scholar
• Lemaitre B, Nicolas E, Michaut L, Reichhart JM, Hoffmann JA. The dorsoventral regulatory gene cassette spatzle/Toll/cactus controls the potent antifungal response in Drosophila adults. Cell. 1996;86(6):973–983.
   PubMed Web of Science ®Google Scholar
• Ignacio G, Nordone S, Howard KE, Dean GA. Toll-like receptor expression in feline lymphoid tissues. Vet Immunol Immunopathol. 2005;106(3):229–237.
   PubMed Web of Science ®Google Scholar
• Qureshi ST, Medzhitov R. Toll-like receptors and their role in experimental models of microbial infection. Genes Immun. 2003;4(2):87–94.
   PubMed Web of Science ®Google Scholar
• Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell. 2006;124(4):783–801.
   PubMed Web of Science ®Google Scholar
• Yu L, Wang L, Chen S. Endogenous toll-like receptor ligands and their biological significance. J Cell Mol Med. 2010;14(11):2592–2603.
   PubMed Web of Science ®Google Scholar
• Chao W. Toll-like receptor signaling: a critical modulator of cell survival and ischemic injury in the heart. Am J Physiol Heart Circ Physiol. 2009;296(1):H1–12.
   PubMed Web of Science ®Google Scholar
• Cairns B, Maile R, Barnes CM, Frelinger JA, Meyer AA. Increased toll-like receptor 4 expression on T cells may be a mechanism for enhanced T cell response late after burn injury. J Trauma. 2006;61(2):293–298.
   PubMedGoogle Scholar
• Kruger B, Krick S, Dhillon N, et al. Donor toll-like receptor 4 contributes to ischemia and reperfusion injury following human kidney transplantation. Proc Natl Acad Sci USA. 2009;106(9):3390–3395.
   PubMed Web of Science ®Google Scholar
• Tsujimoto H, Ono S, Efron PA, et al. Role of toll-like receptors in the development of sepsis. Shock. 2008;29(3):315–321.
   PubMed Web of Science ®Google Scholar
• Monaco C, Gregan SM, Navin TJ, et al. Toll-like receptor-2 mediates inflammation and matrix degradation in human atherosclerosis. Circulation. 2009;120:2462–2469.
   PubMed Web of Science ®Google Scholar
• Cole JE, Navin TJ, Cross AJ, et al. Unexpected protective role for toll-like receptor 3 in the arterial wall. PNAS. 2011;108(24):2372–2377.
   PubMedGoogle Scholar
• Rakoff-Nahoum S, Medzhitov R. Role of toll-like receptors in tissue repair and tumorigenesis. Biochemistry. 2008;73(5):555–561.
   PubMed Web of Science ®Google Scholar
• Zhang J, Xu K, Ambati B, Fu-Shin XY. Toll-like receptor 5-mediated corneal epithelial inflammatory responses to Pseudomonas aeruginosa flagellin. Invest Ophthalmol Vis Sci. 2003;44(10):4247–4254.
   PubMed Web of Science ®Google Scholar
• Gribar SC, Sodhi CP, Richardson WM, et al. Reciprocal expression and signaling of TLR4 and TLR9 in the pathogenesis and treatment of necrotizing enterocolitis. J Immunol. 2009;182(1):636–646.
   PubMed Web of Science ®Google Scholar
• Caplan MS, Simon D, Jilling T. The role of PAF, TLR, and the inflammatory response in neonatal necrotizing enterocolitis. Semin Pediatr Surg. 2005;14(3):145–151.
   PubMedGoogle Scholar
• Clarke DL, Davis NH, Majithiya JB, et al. Development of a mouse model mimicking key aspects of a viral asthma exacerbation. Clin Sci (Lond). 2014;126(8):567–580.
   PubMed Web of Science ®Google Scholar
• Nadeem A, Siddiqui N, Al-Harbi NO, Al-Harbi MM, Ahmad SF. TLR-7 agonist attenuates airway reactivity and inflammation through Nrf2-mediated antioxidant protection in a murine model of allergic asthma. Int J Biochem Cell Biol. 2016;73:53–62.
   PubMed Web of Science ®Google Scholar
• Netea MG, Van der Graaf CA, Vonk AG, et al. The Role of toll-like receptor (TLR) 2 and TLR4 in the host defense against disseminated candidiasis. J Infect Dis. 2002;185(10):1483–1489.
   PubMed Web of Science ®Google Scholar
• Van der Heijden IM, Wilbrink B, Tchetverikov I, et al. Presence of bacterial DNA and bacterial peptidoglycans in the joints of patients with rheumatoid arthritis and other arthritides. Arthritis Rheum. 1998;41(9):S162.
   Google Scholar
• Barrat FJ, Meeker T, Gregorio J, et al. Nucleic acids of mammalian origin can act as endogenous ligands for toll-like receptors and may promote systemic lupus erythematosus. J Exp Med. 2005;202(8):1131–1139.
   PubMed Web of Science ®Google Scholar
• Prinz M, Garbe F, Schmidt H, et al. Innate immunity mediated by TLR9 modulates pathogenicity in an animal model of multiple sclerosis. J Clin Invest. 2006;116(2):456–464.
   PubMed Web of Science ®Google Scholar
• Akahoshi T, Murakami Y, Kitasato H. Recent advances in crystal-induced acute inflammation. Curr Opin Rheumatol. 2007;19(2):146–150.
   PubMed Web of Science ®Google Scholar
• Shchebliakov DV, Logunov DY, Tukhvatulin AI, et al. Toll-like receptors (TLRs): the role in tumor progression. Acta Naturae. 2010;2(3):21–29.
   PubMed Web of Science ®Google Scholar
• Yu L, Chen S. Toll-like receptors expressed in tumor cells: targets for therapy. Cancer Immunol Immunother. 2008;57(9):1271–1278.
   PubMed Web of Science ®Google Scholar
• Rakoff-Nahoum S, Medzhitov R. Toll-like receptors and cancer. Nat Rev Cancer. 2009;9(1):57–63.
   PubMed Web of Science ®Google Scholar
• Molteni M, Marabella D, Orlandi C, Rossetti C. Melanoma cell lines are responsive in vitro to lipopolysaccharide and express TLR-4. Cancer Lett. 2006;235(1):75–83.
   PubMed Web of Science ®Google Scholar
• Kaczanowska S, Joseph AM, Davila E. TLR agonists: our best frenemy in cancer immunotherapy. J Leukoc Biol. 2013;93(6):847–863.
   PubMed Web of Science ®Google Scholar
• Paulos CM, Kaiser A, Wrzesinski C, et al. Toll-like receptors in tumor immunotherapy. Clin Cancer Res. 2007;13(18):5280–5289.
   PubMed Web of Science ®Google Scholar
• Van Duin D, Medzhitov R, Shaw AC. Triggering TLR signaling in vaccination. TRENDS Immunol. 2006;27(1):49–55.
   PubMed Web of Science ®Google Scholar
• Akira S, Takeda K. Toll-like receptor signalling. Nat Rev Immunol. 2004;4(7):499–511.
   PubMed Web of Science ®Google Scholar
• Lin SC, Lo YC, Wu H. Helical assembly in the MyD88-IRAK4-IRAK2 complex in TLR/IL-1R signalling. Nature. 2010;465(7300):885–890.
   PubMed Web of Science ®Google Scholar
• Wang C, Deng L, Hong M, et al. TAK1 is a ubiquitin-dependent kinase of MKK and IKK. Nature. 2001;412(6844):346–351.
   PubMed Web of Science ®Google Scholar
• Takeuchi O, Takeda K, Hoshino K, et al. Cellular responses to bacterial cell wall components are mediated through MyD88-dependent signaling cascades. Int Immunol. 2000;12(1):113–117.
   PubMed Web of Science ®Google Scholar
• Hoebe K, Du X, Georgel P, Janssen E. Identification of Lps2 as a key transducer of MyD88-independent TIR signalling. Nature. 2003;424(6850):743–748.
   PubMedGoogle Scholar
• Kawai T, Akira S. TLR signaling. Cell Death Differ. 2006;13(5):816–825.
   PubMed Web of Science ®Google Scholar
• Toshchakov V, Jones BW, Perera PY, et al. TLR4, but not TLR2, mediates IFN-binduced STAT1a/b-dependent gene expression in macrophages. Nat Immunol. 2002;3(4):392–398.
   PubMed Web of Science ®Google Scholar
• Jiang X, Chen ZJ. The role of ubiquitylation in immune defence and pathogen evasion. Nat Rev Immunol. 2012;12(1):35–48.
   PubMed Web of Science ®Google Scholar
• Beutler B. SHIP, TGF-beta, and endotoxin tolerance. Immunity. 2004;21(2):134–135.
   PubMed Web of Science ®Google Scholar
• Biswas SK, Tergaonkar V. Myeloid differentiation factor 88-independent toll-like receptor pathway: sustaining inflammation or promoting tolerance. Int J Biochem Cell Biol. 2007;39(9):1582–1592.
   PubMed Web of Science ®Google Scholar
• Yasukawa H, Sasaki A, Yoshimura A. Negative regulation of cytokine signaling pathways. Annu Rev Immunol. 2000;18(1):143–164.
   PubMedGoogle Scholar
• Kinjyo I, Hanada T, Inagaki-Ohara K, et al. SOCS1/JAB is a negative regulator of LPS induced macrophage activation. Immunity. 2002;17(5):583–591.
   PubMed Web of Science ®Google Scholar
• Wesche H, Gao X, Li X, et al. IRAK-M is a novel member of the Pelle/interleukin-1 receptor-associated kinase (IRAK) family. J Biol Chem. 1999;274(27):19403–19410.
   PubMed Web of Science ®Google Scholar
• Burns K, Janssens S, Brissoni B, et al. Inhibition of interleukin 1 receptor/Toll-like receptor signaling through the alternatively spliced, short form of MyD88 is due to its failure to recruit IRAK-4. 2003 J Exp Med.;197(2):263–268.
   Google Scholar
• Ziegler-Heitbrock L. The p50-homodimer mechanism in tolerance to LPS. J Endotoxin Res. J Endotoxin Res. 2001;7(3):219–222.
   PubMedGoogle Scholar
• Brint EK, Xu D, Liu H, et al. ST2 is an inhibitor of interleukin receptor and Toll-like receptor 4 signaling and maintains endotoxin tolerance. Nat Immunol. 2004;5(4):373–379.
   PubMed Web of Science ®Google Scholar
• Wald D, Qin J, Zhao Z, et al. SIGIRR, a negative regulator of Toll-like receptor-interleukin 1 receptor signaling. Nat Immunol. 2003;4(9):920–927.
   PubMed Web of Science ®Google Scholar
• An H, Hou J, Zhou J, et al. Phosphatase SHP-1 promotes TLR-and RIG-I-activated production of type I interferon by inhibiting the kinase IRAK1. Nat Immunol. 2008;9(5):542–550.
   PubMed Web of Science ®Google Scholar
• McCoy CE, Carpenter S, Pålsson-McDermott EM, Gearing LJ, O'Neill LA. Glucocorticoids inhibit IRF3 phosphorylation in response to Toll-like receptor-3 and -4 by targeting TBK1 activation. J Biol Chem. 2008;283(21):14277–14285.
   PubMed Web of Science ®Google Scholar
• Carty M, Goodbody R, Schroder M, et al. The human adaptor SARM negatively regulates adaptor protein TRIF-dependent Toll-like receptor signaling. Nat Immunol. 2006;7(10):1074–1081.
   PubMed Web of Science ®Google Scholar
• David NF. Factors affecting gene expression. Merck Manual. 2013.
   Google Scholar
• Lukas J, Lukas C, Bartek J. More than just a focus: the chromatin response to DNA damage and its role in genome integrity maintenance. Nat Cell Biol. 2011;13(10):1161–1169.
   PubMed Web of Science ®Google Scholar
• Stranger BE, Forrest MS, Dunning M, et al. Relative impact of nucleotide and copy number variation on gene expression phenotypes. Science. 2007;315(5813):848–853.
   PubMed Web of Science ®Google Scholar
• Vignal A, Milan D, SanCristobal M, Eggen A. A review on SNP and other types of molecular markers and their use in animal genetics. Genet Sel Evol. 2002;34(3):275–306.
   PubMed Web of Science ®Google Scholar
• Corden J, Wasylyk B, Buchwalder A, et al. Promoter sequences of eukaryotic protein-coding genes. Science. 1980;209(4463):1406–1414.
   PubMed Web of Science ®Google Scholar
• Kaslow RA, McNicholl J, Hill AV, (Eds.) Genetic Susceptibility to Infectious Diseases. USA: Oxford University Press; 2008.
   Google Scholar
• Coussens LM, Werb Z. Inflammation and cancer. Nature. 2002;420(6917):860–867.
   PubMed Web of Science ®Google Scholar
• Polyak K, Weinberg RA. Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nat Rev Cancer. 2009;9(4):265–273.
   PubMed Web of Science ®Google Scholar
• Lauffenburger DA, Horwitz AF. Cell migration: a physically integrated molecular process. Cell. 1996;84(3):359–369.
   PubMed Web of Science ®Google Scholar
• Brachat A, Pierrat B, BruÈngger A, Heim J. Comparative microarray analysis of gene expression during apoptosis-induction by growth factor deprivation or protein kinase C inhibition. Oncogene. 2000;19(44):5073–5082.
   PubMed Web of Science ®Google Scholar
• Herrera RE, Sah VP, Williams BO, et al. Altered cell cycle kinetics, gene expression, and G1 restriction point regulation in Rb-deficient fibroblasts. Mole Cell Biol. 1996;16(5):2402–2407.
   PubMed Web of Science ®Google Scholar
• Lobo I. Environmental influences on gene expression. Nat Edu. 2008;1(1):39.
   Google Scholar
• Basu M, Paichha M, Swain B, et al. Modulation of TLR2, TLR4, TLR5, NOD1 and NOD2 receptor gene expressions and their downstream signaling molecules following thermal stress in the Indian major carp catla (Catla catla). Biotech. 2015;5(6):1021–1030.
   Google Scholar
• Yan X, Xiu F, An H, et al. Fever range temperature promotes TLR4 expression and signaling in dendritic cells. Life Sci. 2007;80(4):307–313.
   PubMed Web of Science ®Google Scholar
• Sophia I, Sejian V, Bagath M, et al. Quantitative expression of hepatic toll-like receptors 1–10 mRNA in Osmanabadi goats during different climatic stresses. Small Rumin Res. 2016;141:11–16.
   Web of Science ®Google Scholar
• Sophia I, Sejian V, Bagath M, Bhatta R. influence of different environmental stresses on various spleen toll-like receptors genes in Osmanabadi goats. Asian J Biol Sci. 2016; DOI: 10.3923/ajbs.2016.
   Google Scholar
• Rehli M. Of mice and men: species variations of toll-like receptor expression. Trends Immunol. 2002;23(8):375–378.
   PubMed Web of Science ®Google Scholar
• Muzio M, Bosisio D, Polentarutti N, et al. Differential expression and regulation of toll-like receptors (TLR) in human leukocytes: selective expression of TLR3 in dendritic cells. J Immunol. 2000;164(11):5998–6004.
   PubMed Web of Science ®Google Scholar
• Matsuguchi T, Musikacharoen T, Ogawa T, Yoshikai Y. Gene expressions of Toll-like receptor 2, but not Toll-like receptor 4, is induced by LPS and inflammatory cytokines in mouse macrophages. J Immunol. 2000;165(10):5767–5772.
   PubMed Web of Science ®Google Scholar
• Jann OC, Werling D, Chang JS, Haig D, Glass EJ. Molecular evolution of bovine Toll-like receptor 2 suggests substitutions of functional relevance. BMC Evol Biol. 2008;8(1):288.
   PubMedGoogle Scholar
• Alvarez-Rodriguez L, Lopez-Hoyos M, Garcia-Unzueta M, et al. Age and low levels of circulating vitamin D are associated with impaired innate immune function. J Leukoc Biol. 2012;91(5):829–838.
   PubMed Web of Science ®Google Scholar
• Boehmer ED, Goral J, Faunce DE, Kovacs EJ. Age-dependent decrease in Toll-like receptor 4-mediated proinflammatory cytokine production and mitogen-activated protein kinase expression. J Leukoc Biol. 2004;75(2):342–349.
   PubMed Web of Science ®Google Scholar
• Renshaw M, Rockwell J, Engleman C, et al. Cutting edge: impaired toll-like receptor expression and function in aging. J Immunol. 2002;169(9):4697–4701.
   PubMed Web of Science ®Google Scholar
• Stewart LK, Flynn MG, Campbell WW, et al. Influence of exercise training and age on CD14+ cell-surface expression of toll-like receptor 2 and 4. Brain Behav Immun. 2005;19(5):389–397.
   PubMed Web of Science ®Google Scholar
• Yao XD, Fernandez S, Kelly MM, Kaushic C, Rosenthal KL. Expression of toll-like receptors in murine vaginal epithelium is affected by the estrous cycle and stromal cells. J Reprod Immunol. 2007;75(2):106–119.
   PubMed Web of Science ®Google Scholar
• Rettew JA, Huet YM, Marriott I. Estrogens augment cell surface TLR4 expression on murine macrophages and regulate sepsis susceptibility in vivo. Endocrinology. 2009;150(8):3877–3884.
   PubMed Web of Science ®Google Scholar
• Nicol T, Bilbey DL, Charles LM, Cordingley JL, Vernon-Roberts B. Oestrogen: the natural stimulant of body defence. J Endocrinol. 1964;30(3):277–291.
   PubMed Web of Science ®Google Scholar
• Rettew JA, Huet-Hudson YM, Marriott I. Testosterone reduces macrophage expression in the mouse of toll-like receptor 4, a trigger for inflammation and innate immunity. Biol Reprod. 2008;78(3):432–437.
   PubMed Web of Science ®Google Scholar
• Kim SY, Choi YJ, Joung SM, et al. Hypoxic stress up‐regulates the expression of toll‐like receptor 4 in macrophages via hypoxia‐inducible factor. Immunology. 2010;129(4):516–524.
   PubMed Web of Science ®Google Scholar
• Dasu MR, Devaraj S, Zhao L, Hwang DH, Jialal I. High glucose induces toll-like receptor expression in human monocytes. Diabetes. 2008;57(11):3090–3098.
   PubMed Web of Science ®Google Scholar
• Nakahira K, Kim HP, Geng XH, et al. Carbon monoxide differentially inhibits TLR signaling pathways by regulating ROS-induced trafficking of TLRs to lipid rafts. J Exp Med. 2006;203(10):2377–2389.
   PubMed Web of Science ®Google Scholar
• Gleeson M, McFarlin B, Flynn M. Exercise and toll-like receptors. Exerc Immunol Rev. 2006;12(1):34–53.
   PubMedGoogle Scholar
• Nagase H, Okugawa S, Ota Y, et al. Expression and function of Toll-like receptors in eosinophils: activation by Toll-like receptor 7 ligand. J Immunol. 2003;171(8):3977–3982.
   PubMed Web of Science ®Google Scholar
• Devaraj S, Dasu MR, Rockwood J, et al. Increased toll-like receptor (TLR) 2 and TLR4 expression in monocytes from patients with type 1 diabetes: further evidence of a proinflammatory state. J Clin Endocrinol Metab. 2008;93(2):578–583.
   PubMed Web of Science ®Google Scholar
• Dasu MR, Devaraj S, Park S, Jialal I. Increased toll-like receptor (TLR) activation and TLR ligands in recently diagnosed type 2 diabetic subjects. Diabetes Care. 2010;33(4):861–868.
   PubMed Web of Science ®Google Scholar
• Zhang E, Lu M. Toll-like receptor (TLR)-mediated innate immune responses in the control of hepatitis B virus (HBV) infection. Med Microbiol Immunol. 2015;204(1):11–20.
   PubMed Web of Science ®Google Scholar
• Hausmann M, Kiessling S, Mestermann S, et al. Toll-like receptors 2 and 4 are up-regulated during intestinal inflammation. Gastroenterology. 2002;122(7):1987–2000.
   PubMed Web of Science ®Google Scholar
• Miyaso H, Morimoto Y, Ozaki M, et al. Obstructive jaundice increases sensitivity to lipopolysaccharide via TLR4 upregulation: possible involvement in gut‐derived hepatocyte growth factor‐protection of hepatocytes. J Gastroenterol Hepatol. 2005;20(12):1859–1866.
   PubMed Web of Science ®Google Scholar
• Feng Y, Chao W. Toll-like receptors and myocardial inflammation. Int J Inflam. 2011;170352:1–21.
   Google Scholar
• Hritz I, Mandrekar P, Velayudham A, et al. The critical role of toll‐like receptor (TLR) 4 in alcoholic liver disease is independent of the common TLR adapter MyD88. Hepatology. 2008;48(4):1224–1231.
   PubMedGoogle Scholar
• Delneste Y, Beauvillain C, Jeannin P. Innate immunity: structure and function of TLRs. Med Sci (Paris). 2007;23(1):67–73.
   PubMed Web of Science ®Google Scholar
• Barton GM, Kagan JC, Medzhitov R. Intracellular localization of Toll-like receptor 9 prevents recognition of self DNA but facilitates access to viral DNA. Nat Immunol. 2006;7(1):49–56.
   PubMed Web of Science ®Google Scholar
• Medzhitov R, Janeway CA. Decoding the patterns of self and nonself by the innate immune system. Science. 2002;296(5566):298–300.
   PubMed Web of Science ®Google Scholar
• Edelmann KH, Richardson-Burns S, Alexopoulou L, et al. Does Toll-like receptor 3 play a biological role in virus infections?. Virology. 2004;322(2):231–238.
   PubMed Web of Science ®Google Scholar
• Sophia I, Sejian V, Bagath M, Bhatta R. Impact of heat stress on immune responses of livestock: a review. Pertanika J Trop Agric Sci. 2016;39(4):459–482.
   Google Scholar
• Takeda K, Akira S. Toll-like receptors in innate immunity”. Int Immunol. 2005;17(1):1–14.
   PubMed Web of Science ®Google Scholar
• Sharma N, Akhade AS, Qadri A. Sphingosine-1-phosphate suppresses TLR-induced CXCL8 secretion from human T cells. J Leukoc Biol. 2013;93(4):521–528.
   PubMed Web of Science ®Google Scholar
• Sabroe I, Prince LR, Jones EC, et al. Selective roles for toll-like receptor (TLR) 2 and TLR4 in the regulation of neutrophil activation and life span. J Immunol. 2003;170(10):5268–5275.
   PubMed Web of Science ®Google Scholar
• Shim JH, Xiao C, Paschal AE, et al. TAK1, but not TAB1 or TAB2, plays an essential role in multiple signaling pathways in vivo. Genes Dev. 2005;19(22):2668–2681.
   PubMed Web of Science ®Google Scholar
• Kaiser WJ, Offermann MK. Apoptosis induced by the toll-like receptor adaptor TRIF is dependent on its receptor interacting protein homotypic interaction motif. J Immunol. 2005;174(8):4942–4952.
   PubMed Web of Science ®Google Scholar
• Månsson A, Adner M, Höckerfelt U, Cardell LO. A distinct Toll‐like receptor repertoire in human tonsillar B cells, directly activated by Pam3CSK4, R‐837 and CpG‐2006 stimulation. Immunol. 2006;118(4):539–548.
   PubMed Web of Science ®Google Scholar
• Wyllie DH, Kiss-Toth E, Visintin A, et al. Evidence for an accessory protein function for Toll-like receptor 1 in anti-bacterial responses. J Immunol. 2000;165(12):7125–7132.
   PubMed Web of Science ®Google Scholar
• Alexopoulou L, Venetta T, Schnare M, et al. Hyporesponsiveness to vaccination with Borrelia burgdorferi OspA in humans and in TLR1-and TLR2-deficient mice. Nat Med. 2002;8(8):878.
   PubMed Web of Science ®Google Scholar
• Massari P, Visintin A, Gunawardana J, et al. Meningococcal porin PorB binds to TLR2 and requires TLR1 for signaling. J Immunol. 2006;176(4):2373–2380.
   PubMed Web of Science ®Google Scholar
• Wieland CW, Knapp S, Florquin S, et al. Non–Mannose-capped Lipoarabinomannan Induces Lung Inflammation via Toll-like Receptor 2. Am J Respir Crit Care Med. 2004;170(12):1367–1374.
   PubMed Web of Science ®Google Scholar
• Into T, Kiura K, Yasuda M, et al. Stimulation of human Toll‐like receptor (TLR) 2 and TLR6 with membrane lipoproteins of Mycoplasma fermentans induces apoptotic cell death after NF‐κB activation. Cell Microbiol. 2004;6(2):187–199.
   PubMed Web of Science ®Google Scholar
• Schwandner R, Dziarski R, Wesche H, Rothe M, Kirschning CJ. Peptidoglycan-and lipoteichoic acid-induced cell activation is mediated by toll-like receptor 2. J Biol Chem. 1999;274(25):17406–17409.
   PubMed Web of Science ®Google Scholar
• Li M, Chen Q, Shen Y, Liu W. Candida albicans phospholipomannan triggers inflammatory responses of human keratinocytes through Toll‐like receptor 2. Exp Dermatol. 2009;18(7):603–610.
   PubMed Web of Science ®Google Scholar
• Zhu J, Krishnegowda G, Li G, Gowda DC. Proinflammatory responses by glycosylphosphatidylinositols (GPIs) of Plasmodium falciparum are mainly mediated through the recognition of TLR2/TLR1. Exp Parasitol. 2011;128(3):205–211.
   PubMed Web of Science ®Google Scholar
• Opitz B, Schröder NW, Spreitzer I, et al. Toll-like receptor-2 mediates Treponema glycolipid and lipoteichoic acid-induced NF-κB translocation. J Biol Chem. 2001;276(25):22041–22047.
   PubMed Web of Science ®Google Scholar
• Dillon S, Agrawal S, Banerjee K, et al. Yeast zymosan, a stimulus for TLR2 and dectin-1, induces regulatory antigen-presenting cells and immunological tolerance. J Clin Invest. 2006;116(4):916.
   PubMed Web of Science ®Google Scholar
• Asea A, Rehli M, Kabingu E, et al. Novel signal transduction pathway utilized by extracellular HSP70 role of Toll-like receptor (TLR) 2 and TLR4. J Biol Chem. 2002;277(17):15028–15034.
   PubMed Web of Science ®Google Scholar
• Mathur S, Walley KR, Wang Y, Indrambarya T, Boyd JH. Extracellular heat shock protein 70 induces cardiomyocyte inflammation and contractile dysfunction via TLR2. Circ J. 2011;75(10):2445–2452.
   PubMed Web of Science ®Google Scholar
• Scheibner KA, Lutz MA, Boodoo S, et al. Hyaluronan fragments act as an endogenous danger signal by engaging TLR2. J Immunol. 2006;177(2):1272–1281.
   PubMed Web of Science ®Google Scholar
• Bieback K, Lien E, Klagge IM, et al. Hemagglutinin protein of wild-type measles virus activates toll-like receptor 2 signaling. J Virol. 2002;76(17):8729–8736.
   PubMed Web of Science ®Google Scholar
• Matsumoto M, Seya T. TLR3: interferon induction by double-stranded RNA including poly (I: C). Adv Drug Deliv. 2008;60(7):805–812.
   PubMed Web of Science ®Google Scholar
• Ojaniemi M, Glumoff V, Harju K, et al. Phosphatidylinositol 3‐kinase is involved in Toll‐like receptor 4‐mediated cytokine expression in mouse macrophages. Eur J Immunol. 2003;33(3):597–605.
   PubMed Web of Science ®Google Scholar
• Tada H, Nemoto E, Shimauchi H, et al. Saccharomyces cerevisiae‐and Candida albicans‐derived mannan induced production of tumor necrosis factor alpha by human monocytes in a CD14‐and Toll‐like receptor 4‐dependent manner. Microbiol Immunol. 2002;46(7):503–512.
   PubMed Web of Science ®Google Scholar
• Gomi K, Kawasaki K, Kawai Y, Shiozaki M, Nishijima M. Toll-like receptor 4-MD-2 complex mediates the signal transduction induced by flavolipin, an amino acid-containing lipid unique to Flavobacterium meningosepticum. J Immunol. 2002;168(6):2939–2943.
   PubMed Web of Science ®Google Scholar
• Kawasaki K, Nogawa H, Nishijima M. Identification of mouse MD-2 residues important for forming the cell surface TLR4-MD-2 complex recognized by anti-TLR4-MD-2 antibodies, and for conferring LPS and taxol responsiveness on mouse TLR4 by alanine-scanning mutagenesis. J Immunol. 2003;170(1):413–420.
   PubMed Web of Science ®Google Scholar
• Rallabhandi P, Phillips RL, Boukhvalova MS, et al. Respiratory syncytial virus fusion protein-induced toll-like receptor 4 (TLR4) signaling is inhibited by the TLR4 antagonists Rhodobacter sphaeroides lipopolysaccharide and eritoran (E5564) and requires direct interaction with MD-2. MBio. 2012;3(4):e00218–12.
   PubMed Web of Science ®Google Scholar
• Vabulas RM, Ahmad-Nejad P, da Costa C, et al. Endocytosed HSP60s use toll-like receptor 2 (TLR2) and TLR4 to activate the toll/interleukin-1 receptor signaling pathway in innate immune cells. J Biol Chem. 2001;276(33):31332–31339.
   PubMed Web of Science ®Google Scholar
• Campo GM, Avenoso A, Campo S, et al. Molecular size hyaluronan differently modulates toll-like receptor-4 in LPS-induced inflammation in mouse chondrocytes. Biochimie. 2010;92(2):204–215.
   PubMed Web of Science ®Google Scholar
• Brennan TV, Lin L, Huang X, et al. Heparan sulfate, an endogenous TLR4 agonist, promotes acute GVHD after allogeneic stem cell transplantation. Blood. 2012;120(14):2899–2908.
   PubMed Web of Science ®Google Scholar
• Motojima M, Matsusaka T, Kon V, Ichikawa I. Fibrinogen that appears in Bowman's space of proteinuric kidneys in vivo activates podocyte Toll-like receptors 2 and 4 in vitro. Nephron Exp Nephrol. 2010;114(2):39–47.
   Google Scholar
• Triantafilou K, Vakakis E, Orthopoulos G, et al. TLR8 and TLR7 are involved in the host's immune response to human parechovirus 1. Eur J Immunol. 2005;35(8):2416–2423.
   PubMed Web of Science ®Google Scholar
• Hemmi H, Kaisho T, Takeuchi O. Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway. Nat Immunol. 2002;3(2):196–200.
   PubMed Web of Science ®Google Scholar
• Stringfellow DA, Vanderberg HC, Weed SD. Interferon induction by 5-halo-6-phenyl pyrimidinones. J Interferon Res. 1980;1(1):1–4.
   PubMedGoogle Scholar
• Horsmans Y, Berg T, Desager JP, et al. Isatoribine, an agonist of TLR7, reduces plasma virus concentration in chronic hepatitis C infection. Hepatol. 2005;42(3):724–731.
   PubMed Web of Science ®Google Scholar
• Bauer S, Kirschning CJ, Häcker H, et al. Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition. PNAS. 2001;98(16):9237–9242.
   PubMed Web of Science ®Google Scholar
• Leadbetter EA, Rifkin IR, Hohlbaum AM, et al. Chromatin–IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors. Nature. 2002;416(6881):603–607.
   PubMed Web of Science ®Google Scholar
• Chuang TH, Ulevitch RJ. Identification of hTLR10: a novel human Toll-like receptor preferentially expressed in immune cells. Biochimica Biophysica Acta. 2001;1518(1):157–161.
   PubMedGoogle Scholar
• Ikushima H, Nishida T, Takeda K, et al. Expression of toll-like receptors 2 and 4 is downregulated after operation. Surgery. 2004;135(4):376–385.
   PubMed Web of Science ®Google Scholar
• Holmqvist B, Olsson CF, Svensson ML, et al. Expression of nitric oxide synthase isoforms in the mouse kidney: cellular localization and influence by lipopolysaccharide and Toll-like receptor 4. J Mol Histol. 2005;36(8):499–516.
   PubMed Web of Science ®Google Scholar